本期内容提示:
1、$哔哩哔哩(BILI)$ 、$Twitter(TWTR)$ 期权异动,后续走势如何看?
2、医药股集体回调,哪些公司值得逢低配置?
3、LJPC宣布被Innoviva收购,大股东Tang capital解套,哪些公司有复制$La Jolla制药(LJPC)的潜力?
$拼多多(PDD)$查看全文
TonyCheung97262021-03-22 16:12
$La Jolla制药(LJPC)$去年(2020年)八月La Jolla收购另一家公司TTPH$Tetraphase制药(TTPH)$ ,TTPH当时就退市了,哪位大神知道原来持有的TTPH股票啥时候能转成La Jolla的股票呀,谢谢!查看全文
smart_trader2021-01-13 02:35
$Adobe(ADBE)$ $苹果(AAPL)$ $La Jolla制药(LJPC)$
日内交易 day4
今天不太行 盈利77刀 被 ljpc 搞了一把 也找不到什么机会 就此收手 低于平均目标 150刀查看全文
牛唐2020-05-29 22:01
$Tetraphase制药(TTPH)$ 这家公司这么香,竟然有三家上市公司要并购,而且不断出高价:$La Jolla制药(LJPC)$ $AcelRx制药(ACRX)$ Melinta Therapeutics查看全文
chuminhua2020-05-08 22:59
5/7,今年3月,抗生素公司Tetraphase Pharmaceuticals$Tetraphase制药(TTPH)$ 宣布接受AcelRx价值1440万美元的全股权收购。但是另一家公司La Jolla Pharmaceuticals$La Jolla制药(LJPC)$ 又向Tetraphase提出了2200万美元的无约束力收购要约。交易的核心是Tetraphase的抗生素eravacycline(商标为Xe...查看全文
chuminhua2019-11-27 13:01
11/26,La Jolla Pharmaceutical$La Jolla制药(LJPC)$ 披露,在中期审查后,公司已经停止了LJPC-401的关键性临床试验。该药是人铁代谢调节剂hepcidin的合成形式,2年前开展了用于输血依赖性β地中海贫血患者心肌铁超负荷的关键性临床研究。在招募了目标100名受试者的一半后,公司的中期分析显示,药...查看全文
悠然临风2019-07-25 22:21
//@悠然临风: $La Jolla制药(LJPC)$ $Intra-cellular(ITCI)$ ,目前看换的还可以,虽然只是一半一半,至少保存了盈利的果实,这轮操作还算玩得溜,LJPC赚一票换了点ITCI,再小赚了点,回冰头等LJPC跌到7块我再补点,有点小完美,可惜几个磨人的主今年不给力,BLCM和ABEO快阵亡了,今年一轮美药下来...查看全文
$La Jolla制药(LJPC)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001564590-22-029988 Act: 33 Size: 39 KB 网页链接
$La Jolla制药(LJPC)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001564590-22-029987 Act: 33 Size: 39 KB 网页链接
$La Jolla制药(LJPC)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001564590-22-029989 Act: 33 Size: 39 KB 网页链接
$La Jolla制药(LJPC)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001564590-22-029990 Act: 33 Size: 39 KB 网页链接
$La Jolla制药(LJPC)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001564590-22-029991 Act: 33 Size: 39 KB 网页链接
$La Jolla制药(LJPC)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-22-000471 Act: 34 Size: 2 KB 网页链接
$La Jolla制药(LJPC)$ SC 14D9/A [Amend] Solicitation, recommendation statements Accession Number: 0001193125-22-226104 Act: 34 Size: 17 KB 网页链接
$La Jolla制药(LJPC)$ 8-K Current report, items 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, and 9.01 Accession Number: 0001193125-22-226110 Act: 34 Size: 241 KB 网页链接
$La Jolla制药(LJPC)$ SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001193125-22-226088 Act: 34 Size: 42 KB 网页链接
$La Jolla制药(LJPC)$ SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001193125-22-222390 Act: 34 Size: 21 KB 网页链接